Position in INCY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,544,870
+$4,933,010 QoQ
Shares Held
110,664
+36.8% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#151
of 854 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Derivatives in INCY
reported options exposure · as of Sep 30, 2020CallValue
$17,948
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Creative Planning holds $452,608,635 across 219 Biotechnology names. INCY ranks #4 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
127,672 | $63,418,511 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,949 | $23,039,178 | |
| 3 | EXEL |
Exelixis, Inc.
|
270,292 | $14,706,586 | |
| 4 | INCY |
Incyte Corp
This page
|
110,664 | $12,544,870 | |
| 5 | CYTK |
Cytokinetics Inc
|
141,939 | $12,091,783 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
64,120 | $12,008,393 | |
| 7 | ARGX |
Argenx SE
|
12,744 | $11,823,500 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
153,161 | $8,763,872 |
All Filings in INCY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,544,870 | 110,664 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,611,860 | 80,874 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $7,798,681 | 78,958 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,029,147 | 59,299 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,254,517 | 33,106 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,679,778 | 27,742 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,891,550 | 27,386 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,478,392 | 22,366 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $1,276,592 | 21,059 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $1,057,533 | 18,563 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $949,509 | 15,122 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $605,313 | 10,478 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $603,949 | 9,702 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $560,381 | 7,754 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $632,841 | 7,879 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $573,770 | 8,610 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $755,977 | 9,951 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $529,016 | 6,661 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $630,652 | 8,592 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $505,326 | 7,347 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $614,990 | 7,310 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $575,716 | 7,084 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $653,393 | 7,512 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $17,948 | 200 | Call | Sole | 2020-11-05 | |
| 2020-09-30 | $638,230 | 7,112 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $703,980 | 6,771 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $510,413 | 6,970 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||